Galectin Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Atlanta, GA USA
Total Funding:$18.5M
Industry:Pharma
Founded:2000
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Galectin Therapeutics's total funding is $18.5M.

Employee Data

  • Galectin Therapeutics has 45 Employees.(?)
  • Galectin Therapeutics currently has 1 job openings.

Pro-Pharmaceuticals is a drug development company commercializing a new generation of anti-cancer treatments using carbohydrate molecules to significantly upgrade the safety and efficacy of standard cancer agents. Trading under the symbol PROH.OB, the company is headquartered in Newton, Mass., and was founded in 2000.

keywords:N/A